Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
Authors:
- 16 March 2026
- journal article
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (4) , 622-641.e11
Abstract
No abstract availableKeywords
Funding Information
- Fudan University (2023ZD0502200)
- National Natural Science Foundation of China (24FCB02)
- National Natural Science Foundation of China (82473255)
- National Natural Science Foundation of China (81972846)
- National Natural Science Foundation of China (32425016)
This publication has 127 references indexed in Scilit:
- Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting AssessmentAdvanced Materials, 2024
- LncRNA NR2F2‐AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR‐32‐5p/SEMA3A axisThe Kaohsiung Journal of Medical Sciences, 2024
- Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistanceCancer and Metastasis Reviews, 2024
- Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023Annals of Oncology, 2023
- Exploring Epigenomic Datasets by ChIPseekerCurrent Protocols, 2022
- Current perspective on the regulation of FOXO4 and its role in disease progressionCellular and Molecular Life Sciences, 2019
- HDAC5–LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cellsInternational Journal of Cancer, 2018
- MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitryTumor Biology, 2014
- A Description of the Molecular Signatures Database (MSigDB) Web Site2014
- EMT-activating transcription factors in cancer: beyond EMT and tumor invasivenessCellular and Molecular Life Sciences, 2012